Global Probiotic Supplements Market (2018 – 2027)

Global Probiotic Supplements Market (2018 – 2027)

$2950

SKU: 802 Category: Tag:

Description

The global probiotic supplements market is projected to expand at a compound annual growth rate (CAGR) of 10.43%, and will reach USD 3.28 Bn by 2027. Awareness about health and fitness is augmenting the need for nutritional diets and maintenance of healthy microbiota, thereby propelling the demand for probiotic supplements.
Form segment insights:
Probiotics are consumed mostly in dry form as capsules, powder, chewable, and tablets. The rising adoption of gummies and chewable probiotic supplements is expected to increase the growth of the dry probiotics market across the world. The dry probiotic supplements segment held a market share of 83% in 2017. The development of dry probiotic supplements for chronic diseases will fuel the growth of the segment, at an expected CAGR of 10.15% during the 2018-2027 period.
Source segment insights:
Based on the source, the market was dominated by the bacteria-based probiotic supplements segment, with a 91% share in 2017. Most probiotic supplements include bacterial strains, of which, Lactobacillus sp and Bifidobacterium sp are used widely for the maintenance of healthy microbiota.
Distribution channel segment insights:
The pharmacy store-based probiotic supplements segment was the leading contributor to the global probiotic supplements market, having generated 46% of the market value in 2017. However, the online store-based probiotic supplements segment is expected to witness the highest expansion, at a CAGR of 13.49% during the 2018-2027 period. The key online distribution channels for probiotic supplements include Amazon, Costco, and The Vitamin Shoppe, among others.
Application segmentation insights:
The segment for gastrointestinal health will be the leading contributor to the global probiotic supplements market, and is anticipated to contribute approximately 64% to the global market value by 2027. The reason for being the leading application segment can be attributed to the increasing prevalence of digestive diseases and diarrhea, due to changing food habits and lifestyle, especially in developing countries.
Regional insights:
The North America probiotic supplements market is projected to expand at a CAGR of 10.68% during the 2018-2027 period, leading to a global revenue of USD 1483.1 Mn by 2027. Increasing awareness about the benefits of probiotic supplements, and inclinations towards preventive care will aid the growth of the market. The Asia-Pacific probiotic supplements market is expected to expand at the highest CAGR of 11.34% between 2018 and 2027.

Companies covered:
• Sanofi
• The Procter & Gamble Company
• Novartis
• i-Health, Inc.
• Taisho Pharmaceutical Holdings Co., Ltd.
• BioGaia
• Bayer Group
• Probi AB
• RENEW LIFE
• Danisco A/S

Customizations available

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

Chapter 1: Executive summary
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary – I
1.4. Executive summary – II

Chapter 2: Global probiotic supplements market – overview
2.1. Global market overview – market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
2.2. Global market drivers and challenges
2.3. Value chain analysis
2.4. Porter’s five forces analysis
2.5. Strategic imperatives for success and growth
2.6. Market size – based on source (bacteria and yeast)
2.6. a. Bacteria – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.5. 6. Yeast – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

2.7. Market size – based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
2.7. a. Liquid – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b. Dry – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.i. Capsules – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.ii. Chewable – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.iii. Tablets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b.iv. Powder – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.7. b. v. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

2.8. Market size – based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
2.8. a. Pharmacy – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. b. Hypermarkets/supermarkets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. c. Online sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. d. Specialty stores – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.8. e. Direct sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

2.9. Market size – based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
2.9. a. Gastrointestinal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. b. Immune health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. c. Vaginal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. d. Urinary tract health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. e. Oral health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
2.9. f. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 3: North America probiotic supplements market – overview
3.1. Market overview – market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
3.2. North America market drivers and challenges
3.3. Market size – based on source (bacteria and yeast)
3.3. a. Bacteria – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.3. b. Yeast – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

3.4. Market size – based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
3.4. a. Liquid – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b. Dry – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.i. Capsules – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.ii. Chewable – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.iii. Tablets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.iv. Powder – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.4. b.v. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

3.5. Market size – based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
3.5. a. Pharmacy – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. b. Hypermarkets/supermarkets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. c. Online sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. d. Specialty stores – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.5. e. Direct sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

3.6. Market size – based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
3.6. a. Gastrointestinal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. b. Immune health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. c. Vaginal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. d. Urinary tract health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. e. Oral health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
3.6. f. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 4: Europe probiotic supplements market – overview
4.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
4.2. Europe market drivers and challenges
4.3. Market size – based on source (bacteria and yeast)
4.3. a. Bacteria – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.3. b. Yeast – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

4.4. Market size – based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
4.4. a. Liquid – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b. Dry – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.i. Capsules – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.ii. Chewable – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.iii. Tablets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.iv. Powder – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.4. b.v. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

4.5. Market size – based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
4.5. a. Pharmacy – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. b. Hypermarkets/supermarkets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. c. Online sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. d. Specialty stores – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.5. e. Direct sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

4.6. Market size – based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
4.6. a. Gastrointestinal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. b. Immune health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. c. Vaginal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. d. Urinary tract health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. e. Oral health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
4.6. f. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 5: Asia-Pacific probiotic supplements market – overview
5.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
5.2. Asia-Pacific market drivers and challenges
5.3. Market size – based on source (bacteria and yeast)
5.3. a. Bacteria – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.3. b. Yeast – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

5.4. Market size – based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
5.4. a. Liquid – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b. Dry – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.i. Capsules – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.ii. Chewable – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.iii. Tablets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.iv. Powder – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.4. b.v. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

5.5. Market size – based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
5.5. a. Pharmacy – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. b. Hypermarkets/supermarkets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. c. Online sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. d. Specialty stores – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.5. e. Direct sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

5.6. Market size – based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
5.6. a. Gastrointestinal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. b. Immune health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. c. Vaginal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. d. Urinary tract health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. e. Oral health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
5.6. f. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 6: Latin America probiotic supplements market – overview
6.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
6.2. Latin America market drivers and challenges
6.3. Market size – based on source (bacteria and yeast)
6.3. a. Bacteria – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.3. b. Yeast – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

6.4. Market size – based on form (liquid, dry [capsules, chewable, tablets, powder, others])
6.4. a. Liquid – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b. Dry – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.i. Capsules – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.ii. Chewable – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.iii. Tablets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.iv. Powder – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.4. b.v. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

6.5. Market size – based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
6.5. a. Pharmacy – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. b. Hypermarkets/supermarkets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. c. Online sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. d. Specialty stores – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.5. e. Direct sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

6.6. Market size – based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
6.6. a. Gastrointestinal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. b. Immune health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. c. Vaginal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. d. Urinary tract health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. e. Oral health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
6.6. f. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 7: The Middle East and Africa probiotic supplements market – overview
7.1. Market overview- market trends, market attractiveness analysis, geography-wise market revenue (USD Mn)
7.2. The Middle East and Africa market drivers and challenges
7.3. Market size – based on source (bacteria and yeast)
7.3. a. Bacteria – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.3. b. Yeast – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

7.4. Market size – based on form (liquid, dry [capsules, chewable, tablets, powder, and others])
7.4. a. Liquid – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b. Dry – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.i. Capsules – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.ii. Chewable – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.iii. Tablets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.iv. Powder – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.4. b.v. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

7.5. Market size – based on distribution channel (pharmacy, hypermarkets/supermarkets, online sales, specialty stores, and direct sales)
7.5. a. Pharmacy – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. b. Hypermarkets/supermarkets – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. c. Online sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. d. Specialty stores – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.5. e. Direct sales – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

7.6. Market size – based on application (gastrointestinal health, immune health, vaginal health, urinary tract health, oral health, and others)
7.6. a. Gastrointestinal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. b. Immune health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. c. Vaginal health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. d. Urinary tract health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. e. Oral health – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations
7.6. f. Others – historical (2017) and forecasted (2018-2027) market size (USD Mn), and key market observations

Chapter 8: Competitive landscape
8.1. Market share of key companies
8.2. Sanofi
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Strategic initiatives
8.1.d. Geographical presence
8.1.e. Key numbers
8.3. The Procter & Gamble Company
8.4. Novartis
8.5. i-Health, Inc.
8.6. Taisho Pharmaceutical Holdings Co., Ltd.
8.7. BioGaia
8.8. Bayer Group
8.9. Probi AB
8.10. RENEW LIFE
8.11. Danisco A/S

Chapter 9: Conclusion
Chapter 10: Appendix
10.1. List of tables
10.2. Research methodology
10.3. Assumptions
10.4. About Netscribes Inc.

Related products